FAST NEWS: Clover to Complete Covid Vaccine Applications by Year-End
The latest: Clover Biopharmaceuticals Ltd. (2197.HK) said on Sunday it plans to complete registration applications for its lead Covid-19 vaccine candidate, SCB-2019, with the China National Medical Products Administration, the…
One Man’s Loss Is Nissin Foods’ Gain in Hong Kong Outbreak
Nomura believes the instant noodle maker could be a big beneficiary as panic buying sweeps the Asian financial hub Key takeaways： Nomura says Nissin Foods is profiting from recent panic…
RELATED ARTICLES
-
Dispute over Covid vaccines casts doubt on Clover Bio recovery
2197.HK -
Everest Medicines drives growth with AI-powered mRNA pipeline
1952.HK
-
Zhengye Biotech’s ‘pet-sized’ IPO leaves plenty of room for more fundraising
ZYBT.US
-
WuXi Biologics sells vaccine plant as new U.S. law looms
2269.HK
- As Covid drug cash dwindles, Vigonvita targets new remedies
-
BRIEF: Greentown’s January sales fall 9% year-on-year
3900.HK
